• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声监测年轻女孩特发性性早熟中促性腺激素释放激素类似物的治疗效果

Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls.

作者信息

Hall D A, Crowley W F, Wierman M E, Simeone J F, McCarthy K A

出版信息

J Clin Ultrasound. 1986 Jun;14(5):331-8. doi: 10.1002/jcu.1870140503.

DOI:10.1002/jcu.1870140503
PMID:3088048
Abstract

Precocious puberty in young girls is defined as the development of secondary sexual characteristics and gonadal growth before 8 years of age. Approximately 60% of isosexual precocious development in girls has no organic cause and is termed idiopathic precocious puberty. Thirteen young girls with idiopathic precocious puberty were treated with LHRH analogue under a well-established protocol. Pelvic ultrasound was added to the protocol to examine ultrasound's role in supplying a morphologic parameter of suppression of the pubertal process. Initially, 11 patients had ovarian volumes greater than normal, and ovarian cysts measuring 0.5 cm to 4 cm in diameter were identified in seven patients. All 13 patients had enlarged pretreatment uteri greater than 3 cm in length. Eleven of these patients had a pubertal or adult uterine configuration. After 1 year of therapy, 11 patients had normal prepubertal ovarian volumes, and 12 of 13 patients had a decrease in ovarian volume. No demonstrable cysts were present at 1 year. Eleven had a reduction in uterine length. Nine of the 11 patients with a pubertal uterine configuration reverted to a more prepubertal-like morphology. The sonographic morphologic changes correlated well with laboratory and clinical data indicating suppression of the hypothalamic-pituitary-gonadal axis.

摘要

女童性早熟被定义为8岁前出现第二性征发育和性腺生长。女童同性性早熟中约60%无器质性病因,称为特发性性早熟。13例特发性性早熟女童按照既定方案接受促性腺激素释放激素(LHRH)类似物治疗。该方案增加了盆腔超声检查,以研究超声在提供青春期发育进程抑制的形态学参数方面的作用。最初,11例患者卵巢体积大于正常,7例患者发现直径为0.5 cm至4 cm的卵巢囊肿。所有13例患者治疗前子宫均增大,长度大于3 cm。其中11例患者子宫呈青春期或成人构型。治疗1年后,11例患者卵巢体积恢复至青春期前正常大小,13例患者中有12例卵巢体积减小。1年后未发现明显囊肿。11例患者子宫长度缩短。11例子宫呈青春期构型的患者中有9例恢复为更接近青春期前的形态。超声形态学变化与表明下丘脑-垂体-性腺轴受抑制的实验室和临床数据密切相关。

相似文献

1
Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls.超声监测年轻女孩特发性性早熟中促性腺激素释放激素类似物的治疗效果
J Clin Ultrasound. 1986 Jun;14(5):331-8. doi: 10.1002/jcu.1870140503.
2
Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.用强效促黄体生成素释放因子激动剂治疗真性性早熟:对生长、性成熟、盆腔超声检查及下丘脑-垂体-性腺轴的影响。
J Clin Endocrinol Metab. 1985 Jul;61(1):142-51. doi: 10.1210/jcem-61-1-142.
3
Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues.女童中枢性性早熟:长效促性腺激素释放激素类似物治疗前、治疗期间及治疗后的内生殖器情况
J Pediatr. 1998 Jan;132(1):105-8. doi: 10.1016/s0022-3476(98)70493-7.
4
The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.美国国立卫生研究院(NIH)对性早熟的研究经验:诊断亚组及对短期促黄体生成素释放激素类似物治疗的反应
J Pediatr. 1986 Jan;108(1):47-54. doi: 10.1016/s0022-3476(86)80767-3.
5
[Ovarian cysts and tumors as the cause of isosexual pseudoprecocious puberty].[卵巢囊肿和肿瘤作为同性性早熟的病因]
Srp Arh Celok Lek. 2006 Jul-Aug;134(7-8):305-9. doi: 10.2298/sarh0608305m.
6
Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.性早熟女童停用促性腺激素释放激素类似物治疗后的生殖轴:下丘脑错构瘤女童与特发性性早熟女童的长期随访比较
J Clin Endocrinol Metab. 1999 Jan;84(1):44-9. doi: 10.1210/jcem.84.1.5409.
7
[Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].[每六周皮下注射促性腺激素释放激素激动剂治疗特发性中枢性性早熟女童的临床研究]
Zhonghua Er Ke Za Zhi. 2004 Nov;42(11):845-9.
8
Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.中枢性性早熟女童性腺甾体激素分泌受抑制期间生长及血清生长激素和血浆生长调节素C水平的变化
J Clin Endocrinol Metab. 1988 Jan;66(1):3-9. doi: 10.1210/jcem-66-1-3.
9
Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.正常青春期及真性性早熟患者在使用强效促黄体生成素释放激素激动剂治疗前后的生长调节素C
J Clin Endocrinol Metab. 1985 Jul;61(1):152-9. doi: 10.1210/jcem-61-1-152.
10
Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.通过定期给予长效D-色氨酸6-促黄体生成素释放激素微胶囊制剂对男性和女性性早熟进行长期治疗。
J Clin Endocrinol Metab. 1986 Apr;62(4):670-7. doi: 10.1210/jcem-62-4-670.

引用本文的文献

1
The role of pelvic ultrasound for the diagnosis and management of central precocious puberty: An update.盆腔超声在中枢性性早熟的诊断和治疗中的作用:更新。
Acta Biomed. 2021 Nov 4;92(5):e2021480. doi: 10.23750/abm.v92i5.12295.
2
Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty.盆腔超声在诊断和评估促性腺激素释放激素激动剂治疗特发性中枢性性早熟女童疗效中的应用
Front Pharmacol. 2019 Feb 11;10:104. doi: 10.3389/fphar.2019.00104. eCollection 2019.
3
Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty.
J Endocrinol Invest. 1995 Feb;18(2):98-103. doi: 10.1007/BF03349708.